MedTrace Logo

Romanian National Registry of Outcomes After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis - RO-TAVI

NCT04694859 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-01-05

No results posted yet for this study

Summary

RO-TAVI is a national prospective, observational, multi-center registry registry of patients with aortic valve stenosis undergoing transcatheter aortic valve implantation (TAVI) to assess patient care and outcomes.

Conditions

  • Aortic Stenosis Symptomatic
  • Aortic Valve Stenosis

Interventions

DEVICE

Transcatheter Aortic Valve Implantation

Transfemoral or transapical Transcatheter Aortic Valve Implantation

Sponsors & Collaborators

  • Romanian Society of Cardiology

    lead OTHER

Principal Investigators

  • Vlad A Iliescu, MD PhD · University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania

  • Bogdan A Popescu, MD PhD · University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania

  • Dragos Vinereanu, MD PhD · University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-05
Primary Completion
2022-12-30
Completion
2023-07-30
FDA Device
Yes

Countries

  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04694859 on ClinicalTrials.gov